Profit Margin (Quarterly) Chart

View Profit Margin (Quarterly) for AVDL.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Profit Margin (Quarterly) Chart
Start Trial

Historical Profit Margin (Quarterly) Data

View and export this data back to 2004. Start Trial.
Date Value
September 30, 2025 0.03%
June 30, 2025 14.19%
March 31, 2025 -9.37%
December 31, 2024 -10.00%
September 30, 2024 -5.25%
June 30, 2024 -33.30%
March 31, 2024 -100.6%
December 31, 2023 -148.0%
September 30, 2023 -517.2%
June 30, 2023 -4.31K%
March 31, 2023
December 31, 2022
September 30, 2022
June 30, 2022
March 31, 2022
December 31, 2021
September 30, 2021
June 30, 2021
March 31, 2021
December 31, 2020
September 30, 2020
June 30, 2020
March 31, 2020 -7.07%
December 31, 2019 -24.91%
September 30, 2019 -62.30%
Date Value
June 30, 2019 -49.02%
March 31, 2019 -79.20%
December 31, 2018 -305.3%
September 30, 2018 -79.55%
June 30, 2018 -11.76%
March 31, 2018 -36.75%
December 31, 2017 -27.04%
September 30, 2017 54.64%
June 30, 2017 62.46%
March 31, 2017 49.35%
December 31, 2016 10.99%
September 30, 2016 -62.31%
June 30, 2016 -51.36%
March 31, 2016 -16.73%
December 31, 2015
September 30, 2015 -62.73%
June 30, 2015 -34.94%
March 31, 2015 35.59%
December 31, 2014 -1.07K%
September 30, 2014 -142.9%
June 30, 2014 -260.7%
March 31, 2014 -586.7%
December 31, 2013
September 30, 2013 -114.1%
June 30, 2013 -592.9%

Profit Margin Definition

Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.

Read full definition.

Profit Margin (Quarterly) Range, Past 5 Years

View Profit Margin (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Profit Margin (Quarterly) Benchmarks

View Profit Margin (Quarterly) Benchmarks
Start Trial
Jazz Pharmaceuticals Plc 15.96%
Perrigo Co. Plc 8.65%
GH Research Plc --
Cosmo NV --
Alkermes Plc 0.10%